We evaluated the presence of insulin secretory dysfunction and insulin resistance before the initiation of CST in 13 patients with new-onset DM, but could not in patients with pre-existing DM because of the influence of diabetic medication. The gene discussed is INS; the disease is diabetes mellitus.